Summary
The product Intex T-400, manufactured by Intex Pharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number O-2334, was submitted by Intex Pharma and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the concentration of its active ingredients:
- Testosterone Enanthate: 133.85 mg/ml
- Testosterone Cypionate: 132.30 mg/ml
- Testosterone Decanoate: 176.15 mg/ml
The testing process began on 8 October 2024, with the sample received on 22 October 2024, and analysis completed on 25 October 2024. While the results confirm the presence of expected compounds, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Intex Pharma
- Product Name: Intex T-400
- Active Ingredients: Testosterone Enanthate, Testosterone Cypionate, Testosterone Decanoate
- Batch Number: O-2334
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51210
- Testing Ordered: 8 October 2024
- Sample Received: 22 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Intex Pharma (Manufacturer)
- Analysis Paid For By: Intex Pharma (Manufacturer)
Testing Results
- Testosterone Enanthate: 133.85 mg/ml
- Testosterone Cypionate: 132.30 mg/ml
- Testosterone Decanoate: 176.15 mg/ml
Verification Details
Verification URL: https://janoshik.com/tests/51210_4LJSJJNRXDG8
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the presence of the expected active ingredients in the product. However, since Intex Pharma submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that Intex T-400 contains Testosterone Enanthate, Testosterone Cypionate, and Testosterone Decanoate in concentrations close to expected levels. While this batch exhibits strong quality control, ongoing testing is crucial to ensure consistency across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
